Recent studies from our laboratory suggested that the heparan sulfate proteoglycan–mediated pathway regulates the internalization of BDTOs from AD and DLB, whereas BDTOs from PSP are taken up by heparan sulfate proteoglycan–mediated and other alternative pathways (51). The gene discussed is CD44; the disease is supranuclear palsy, progressive, 1.